Quiz: Why isn’t SGP’s TRA antiplatelet drug on the list, given that Fred Hassan has stated on numerous occasions that the phase-3 clinical program for TRA is too expensive for SGP to pursue on its own?
If this is a low difficulty quiz I would say because SGP has the resources to fund it themselves even though they said its too expensive. I tried cheating (googling) but couldn't find an easy explanation.
BTW how do you quote someone with the lines it seems more clear. Is it a new i-hub feature or using HTML?
Market Data 
Markets 
AI
